SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs > Supernus Pharmaceuticals (SUPN)

1:21AM Supernus Pharma prices 10 mln share IP0

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 415
Posts 22,553
Boards Moderated 3
Alias Born 09/11/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/25/2017 7:09:32 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/9/2017 5:20:36 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/9/2017 4:39:28 PM
Supernus Announces First Quarter 2017 Financial Results "GlobeNewswire Inc." - 5/9/2017 4:15:00 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/27/2017 4:41:23 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/26/2017 4:40:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/26/2017 4:19:03 PM
Supernus to Host First Quarter 2017 Earnings Conference Call "GlobeNewswire Inc." - 4/26/2017 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/24/2017 4:48:47 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/11/2017 4:48:46 PM
Supernus Receives Final FDA Approval for Trokendi XR® for Migraine Prophylaxis in Adults and Adolescents "GlobeNewswire Inc." - 4/5/2017 6:44:08 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/4/2017 4:58:35 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/16/2017 4:20:57 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/9/2017 5:00:03 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/8/2017 4:47:03 PM
Supernus Announces Settlement with Actavis on Trokendi XR® Patent Litigation "GlobeNewswire Inc." - 3/7/2017 1:07:14 PM
Supernus Announces Settlement with Zydus on Trokendi XR® Patent Litigation "GlobeNewswire Inc." - 3/6/2017 5:31:05 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/1/2017 5:03:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/1/2017 6:09:06 AM
Supernus Announces Record Fourth Quarter and Full Year 2016 Financial Results "GlobeNewswire Inc." - 2/28/2017 7:50:17 PM
Supernus to Present at Cowen Health Care Conference in March "GlobeNewswire Inc." - 2/27/2017 4:33:55 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 2/17/2017 5:12:55 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/15/2017 4:47:02 PM
Supernus to Host Fourth Quarter and Full Year 2016 Earnings Conference Call "GlobeNewswire Inc." - 2/13/2017 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/10/2017 4:35:09 PM
surf1944   Tuesday, 05/01/12 08:26:57 AM
Re: None
Post # of 128 
1:21AM Supernus Pharma prices 10 mln share IP0 at $5.00 per share, price in-line with expectations (SUPN) :

Supernus Pharmaceuticals (SUPN), a former Shire sub developing improved drug formulations for epilepsy and ADHD, plans to raise $55 million by offering 11.0 million shares at a price of $5.00. Supernus Pharmaceuticals will command a market value of $125 million. The Rockville, MD-based company, which was founded in 2005, plans to list on the NASDAQ under the symbol SUPN. Citi and Piper Jaffray (PJC) are the joint bookrunners on the deal.

http://seekingalpha.com/article/544941-6-ipos-planned-for-this-week?source=yahoo



surf's up......crikey



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist